MURRYSVILLE, Pa. — Respironics Inc. announced that it has expanded its relationship with Masimo to adopt Masimo’s pulse oximetry solution for situations requiring read through motion technology across all of its business units.
Respironics had only used Masimo SET in certain sleep and respiratory products. Now, Respironics will gradually incorporate Rainbow SET in all Respironics products where the improved capabilities will provide clear clinical improvements. Respironics will phase out its Novametrix MARS™ oximetry product line over time but will continue to service customers until a comprehensive plan is in place.
The agreement between Respironics and Masimo also constitutes a release by Masimo of Respironics and its affiliates from certain patent infringement claims and provides Respironics with access to the Masimo Rainbow SET technology.
“Masimo SET is clearly the gold standard in pulse oximetry technology for its ability to reliably measure oxygen saturation and pulse rate during difficult situations,” says Respironics’ COO Craig Reynolds. “But with its new Rainbow Technology, Masimo further advances the science by being able to simultaneously measure carboxyhemoglobin and methemoglobin noninvasively, which until now could only be measured invasively. Masimo and Respironics have enjoyed a great business relationship for over 10 years. We are excited to be able to extend our existing relationship and again be one of the first companies to provide our customers with the latest advancements in noninvasive patient monitoring technology.”
Respironics stated that it will not change its financial outlook or guidance based on the new agreement.
SOURCE: Respironics Inc.
